국제 경제
Trump Mentions Korea Zinc’s U.S. Smelter Investment, Presenting It as Result of Tariff Policy
- Introduces plans for over $6B investment and 740 jobs at Tennessee campaign rally
Korea Zinc pursues $7.4B integrated smelter to produce 11 critical mineral
Speaking at a Republican campaign rally in Clarksville, Tennessee, on Oct. 10, Trump said Korea Zinc was investing more than $6 billion in Montgomery and Smith counties and would create 740 jobs, according to local media reports published the following day.
He also described the project as the first new mineral smelter to be built in the United States since 1979, arguing that his tariffs had encouraged foreign companies to invest in the country.
Korea Zinc is pursuing Project Crucible, an integrated nonferrous metals smelter in Tennessee, with the U.S. government and other partners. The project has a total planned investment of about $7.4 billion.
The facility is expected to produce 11 minerals designated as critical by the U.S. government, including zinc, lead, copper, silver, antimony, indium, bismuth, tellurium, palladium and gallium.
Commerce Secretary Howard Lutnick also reportedly cited the project at an Aug. 7 roundtable on critical minerals supply chains at the State Department in Washington. He stressed the need to strengthen domestic supply chains.
The International Energy Agency (IEA) and the Center for Strategic and International Studies (CSIS) have also discussed the project in their reports. The IEA cited it as an example of critical minerals supply chain diversification, while CSIS described it as a case of the United States and South Korea jointly developing an industrial ecosystem.
ⓒ이코노미스트(https://economist.co.kr) '내일을 위한 경제뉴스 이코노미스트' 무단 전재 및 재배포 금지






당신이 좋아할 만한 기사
브랜드 미디어
브랜드 미디어
클래시스, 베인 출신 배정희 부사장 영입…글로벌 영업·마케팅 통합
바이오 성공 투자, 1%를 위한 길라잡이팜이데일리
일간스포츠
이데일리
‘마약 실형’ 돈스파이크, 로또 당첨에 신났네…“대박사건” 자랑
대한민국 스포츠·연예의 살아있는 역사 일간스포츠일간스포츠
일간스포츠
일간스포츠
北, 평양서 탄도미사일 발사…軍 "韓 극초음속 성공에 무력시위 가능성"(종합)
세상을 올바르게,세상을 따뜻하게이데일리
이데일리
이데일리
뷰티 유통·B2B 솔루션 매물로…패션 대기업 인수 수요도[M&A 딜보드]
성공 투자의 동반자마켓인
마켓인
마켓인
[단독]월1회·최대 3개월 내세웠던 펩트론…특허 속 효능시험은 최대 2주 간격
바이오 성공 투자, 1%를 위한 길라잡이팜이데일리
팜이데일리
팜이데일리